Litigation Details for Novo Nordisk Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2017)
✉ Email this page to a colleague
Novo Nordisk Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2017)
Docket | ⤷ Sign Up | Date Filed | 2017-03-03 |
Court | District Court, D. Delaware | Date Terminated | 2019-03-18 |
Cause | 35:271 Patent Infringement | Assigned To | Joseph F. Bataillon |
Jury Demand | None | Referred To | Sherry R. Fallon |
Parties | TEVA PHARMACEUTICALS USA, INC. | ||
Patents | 6,235,004; 6,268,343; 8,114,833; 8,846,618; 9,265,893; 9,968,659; RE41,956 | ||
Attorneys | Brian P. Egan; Gregory Springsted | ||
Firms | Morris, Nichols, Arsht & Tunnell | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Novo Nordisk Inc. v. Teva Pharmaceuticals USA, Inc.
Biologic Drugs cited in Novo Nordisk Inc. v. Teva Pharmaceuticals USA, Inc.
The biologic drugs covered by the patents cited in this case are ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .
Details for Novo Nordisk Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2017)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2017-03-02 | 1 | Complaint | United States Patent Nos. 6,268,343 (the “ʼ343 patent”), 8,114,833 (the “ʼ833 patent”), 8,846,618 (the… COUNT FOR INFRINGEMENT OF U.S. PATENT NO. 6,268,343 19. Novo Nordisk re-alleges…(the “ʼ618 patent”), 9,265,893 (the “ʼ893 patent”), and RE41,956 (the “RE ʼ956 patent”), which cover,… 1. This is an action for patent infringement under the patent laws of the United States, Title… THE PATENTS-IN-SUIT 5. On July 31, 2001, the United States Patent and Trademark | External link to document |
2019-03-18 | 101 | Judgment - Consent | event that the claims of U.S. Patent Nos. 6,268,343 (the "'343 patent"), 8,114,833 (the …'"833 patent"), 8,846,618 (the '"618 patent"), 9,265,893 (the "'…#x27;893 patent"), , and RE41,956 (the "RE '956 patent"} asserted against Teva, are…enjoined until expiration of US Patent 9,968,659 ("the '659 patent") and the '343, &…x27;833, '618, '893, and RE '956 Patents would be infringed by any unlicensed manufacture | External link to document |
2019-03-18 | 104 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,268,343 81; 8,114,833 82; 8,846,618…2017 18 March 2019 1:17-cv-00227 830 Patent None District Court, D. Delaware | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |